BioCentury
ARTICLE | Company News

NanoString, Broad Institute of MIT and Harvard deal

April 22, 2013 7:00 AM UTC

NanoString said it received an exclusive option to license worldwide rights to a 186-gene gene signature for liver cancer from Broad Institute. NanoString said the signature could be used to determine...